GILD

Gilead Sciences

Health Care

Biotechnology

Foster City, California

Balance Sheet 34 Accounts • 5 Years

Account	2024	2023	2022	2021	2020
end	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31
Assets - CashAndCashEquivalents	$10.0B	$6.1B	$5.4B	$5.3B	$6.0B
Assets - MarketableSecuritiesCurrent	$0	$1.2B	$973.0M	$1.2B	$1.4B
Assets - AccountsReceivable	$4.4B	$4.7B	$4.8B	$4.5B	$4.9B
Assets - Inventories	$1.7B	$1.8B	$1.5B	$1.6B	$1.7B
Assets - PrepaidExpensesAndOtherCurrentAssets	$3.1B	$2.4B	$1.8B	$2.1B	$2.0B
Assets - ContractAssetsCurrent	$277.0M	$117.0M	$171.0M	$174.0M	$198.0M
Assets - TotalCurrentAssets	$19.2B	$16.1B	$14.4B	$14.8B	$16.0B
Assets - Property,PlantAndEquipment	$5.4B	$5.3B	$5.5B	$5.1B	$5.0B
Assets - Goodwill	$8.3B	$8.3B	$8.3B	$8.3B	$8.1B
Assets - IntangibleAssets(net,ExcludingGoodwill)	$19.9B	$26.5B	$28.9B	$33.5B	$33.1B
Assets - MarketableSecuritiesNoncurrent	$0	$1.2B	$1.2B	$1.3B	$502.0M
Assets - DeferredTaxAssets	$6.0B	$5.5B	$4.7B	$4.1B	$4.0B
Assets - OperatingLeaseAssets	$515.0M	$581.0M	$505.0M	$542.0M	$646.0M
Assets - OtherNoncurrentAssets	$6.1B	$4.8B	$4.8B	$5.0B	$5.7B
Assets - TotalAssets	$59.0B	$62.1B	$63.2B	$68.0B	$68.4B
Liabilities - AccountsPayable	$833.0M	$550.0M	$905.0M	$705.0M	$844.0M
Liabilities - AccruedLiabilities	$2.3B	$2.3B	$2.2B	$6.1B	$4.3B
Liabilities - ContractLiabilitiesCurrent	$321.0M	$387.0M	$422.0M	$499.0M	$587.0M
Liabilities - ShortTermDebtAndCurrentPortionOfLongTermDebt	$1.8B	$1.8B	$2.3B	$1.5B	$2.8B
Liabilities - OperatingLeaseLiabilitiesCurrent	$113.0M	$125.0M	$111.0M	$101.0M	$107.0M
Liabilities - TotalCurrentLiabilities	$12.0B	$11.3B	$11.2B	$11.6B	$11.4B
Liabilities - LongTermDebt	$24.9B	$23.2B	$23.0B	$25.2B	$28.6B
Liabilities - OperatingLeaseLiabilitiesNoncurrent	$498.0M	$546.0M	$467.0M	$489.0M	$608.0M
Liabilities - DeferredTaxLiabilitiesNoncurrent	$724.0M	$1.6B	$2.7B	$4.4B	$3.9B
Liabilities - OtherNoncurrentLiabilities	$1.3B	$1.3B	$1.2B	$976.0M	$1.2B
Equity - PreferredStock	$0	$0	$0	$0	$0
Equity - CommonStock	$1.0M	$1.0M	$1.0M	$1.0M	$1.0M
Equity - AdditionalPaidInCapital	$7.7B	$6.5B	$5.5B	$4.7B	$3.9B
Equity - RetainedEarnings(deficit)	$11.5B	$16.3B	$15.7B	$16.3B	$14.4B
Equity - AccumulatedOtherComprehensiveIncome(loss)	$132.0M	$28.0M	$2.0M	$83.0M	$-60.0M
Equity - NoncontrollingInterest	$-84.0M	$-84.0M	$-31.0M	$-5.0M	$19.0M
Equity - TotalStockholdersEquity	$19.3B	$22.8B	$21.2B	$21.1B	$18.2B
Equity - TotalLiabilitiesAndStockholdersEquity	$59.0B	$62.1B	$63.2B	$68.0B	$68.4B

Income Statement 20 Accounts • 5 Years

Account	2024	2023	2022	2021	2020
end	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31
IncomeStatement - Revenues - NetRevenues/ProductSales	$28.8B	$27.1B	$27.3B	$27.3B	$24.7B
IncomeStatement - CostsAndExpenses - CostOfGoodsSold/CostOfSales	$6.3B	$6.5B	$5.7B	$6.6B	$4.6B
IncomeStatement - CostsAndExpenses - ResearchAndDevelopmentExpense	$5.9B	$5.7B	$5.0B	$4.6B	$4.9B
IncomeStatement - CostsAndExpenses - Selling,GeneralAndAdministrative	$6.1B	$6.1B	$5.7B	$5.2B	$5.2B
IncomeStatement - CostsAndExpenses - AmortizationOfIntangibleAssets(operating)	$2.4B	$2.3B	$1.8B	$1.7B	$1.2B
IncomeStatement - CostsAndExpenses - ImpairmentCharges(operating)	$4.2B	$50.0M	$2.7B	$0	$0
IncomeStatement - OtherIncomeExpense - OperatingIncome(loss)	$1.7B	$7.6B	$7.3B	$9.9B	$4.1B
IncomeStatement - OtherIncomeExpense - OtherNonoperatingIncome(expense)	$6.0M	$198.0M	$-581.0M	$-639.0M	$-1.4B
IncomeStatement - OtherIncomeExpense - Income(loss)BeforeIncomeTaxes	$690.0M	$6.9B	$5.8B	$8.3B	$1.7B
IncomeStatement - IncomeTax - IncomeTaxExpense(benefit)	$211.0M	$1.2B	$1.2B	$2.1B	$1.6B
IncomeStatement - IncomeTax - EffectiveTaxRate	$0	$0	$0	$0	$1
IncomeStatement - NetIncomeAndEps - NetIncome(loss)	$480.0M	$5.7B	$4.6B	$6.2B	$123.0M
IncomeStatement - NetIncomeAndEps - NetIncome(loss)AttributableToNoncontrollingInterest	$0	$-52.0M	$-26.0M	$-24.0M	$-34.0M
IncomeStatement - NetIncomeAndEps - NetIncome(loss)AttributableToCompany	$480.0M	$5.7B	$4.6B	$6.2B	$123.0M
IncomeStatement - NetIncomeAndEps - BasicEarningsPerShare	$0	$5	$4	$5	$0
IncomeStatement - NetIncomeAndEps - DilutedEarningsPerShare	$0	$4	$4	$5	$0
IncomeStatement - NetIncomeAndEps - WeightedAverageSharesOutstandingBasic	$1.2B	$1.2B	$1.3B	$1.3B	$1.3B
IncomeStatement - NetIncomeAndEps - WeightedAverageSharesOutstandingDiluted	$1.3B	$1.3B	$1.3B	$1.3B	$1.3B
IncomeStatement - NetIncomeAndEps - ComprehensiveIncome(loss)	$584.0M	$5.7B	$4.5B	$6.4B	$-22.0M

Cash Flow Statement 25 Accounts • 5 Years

Account	2024	2023	2022	2021	2020
end	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31
CashFlow - OperatingActivities - NetIncome	$480.0M	$5.7B	$4.6B	$6.2B	$123.0M
CashFlow - OperatingActivities - DepreciationAndAmortization	$381.0M	$354.0M	$323.0M	$329.0M	$288.0M
CashFlow - OperatingActivities - ShareBasedCompensation	$835.0M	$766.0M	$637.0M	$635.0M	$643.0M
CashFlow - OperatingActivities - DeferredIncomeTaxes	$-1.8B	$-962.0M	$-1.6B	$-116.0M	$-214.0M
CashFlow - OperatingActivities - ChangesInOperatingAssetsAndLiabilities	$944.0M	$757.0M	$-267.0M	$-72.0M	$1.5B
CashFlow - OperatingActivities - NetCashFromOperatingActivities	$10.8B	$8.0B	$9.1B	$11.4B	$8.2B
CashFlow - InvestingActivities - CapitalExpenditures(pp&e)	$523.0M	$585.0M	$728.0M	$579.0M	$650.0M
CashFlow - InvestingActivities - PurchasesOfMarketableSecurities/investments	$492.0M	$442.0M	$1.8B	$3.5B	$20.3B
CashFlow - InvestingActivities - ProceedsFromSales/maturitiesOfMarketableSecurities/investments	$2.3B	$510.0M	$412.0M	$730.0M	$23.2B
CashFlow - InvestingActivities - AcquisitionsOfBusinesses,NetOfCash	$4.8B	$1.2B	$1.8B	$1.6B	$25.9B
CashFlow - InvestingActivities - OtherInvestingActivities	$-58.0M	$1.0M	$1.0M	$-19.0M	$-7.0M
CashFlow - InvestingActivities - NetCashFromInvestingActivities	$-3.4B	$-2.3B	$-2.5B	$-3.1B	$-14.6B
CashFlow - FinancingActivities - ProceedsFromIssuanceOfDebt	$3.5B	$2.0B	$0	$0	$8.2B
CashFlow - FinancingActivities - RepaymentsOfDebt	$2.0B	$2.2B	$1.5B	$4.8B	$2.5B
CashFlow - FinancingActivities - PaymentsForRepurchaseOfCommonStock	$1.1B	$1.0B	$1.4B	$546.0M	$1.6B
CashFlow - FinancingActivities - PaymentOfDividends	$3.9B	$3.8B	$3.7B	$3.6B	$3.4B
CashFlow - FinancingActivities - ProceedsFromIssuanceOfCommonStock	$422.0M	$232.0M	$309.0M	$169.0M	$256.0M
CashFlow - FinancingActivities - OtherFinancingActivities	$-281.0M	$-279.0M	$-173.0M	$-145.0M	$-138.0M
CashFlow - FinancingActivities - NetCashFromFinancingActivities	$-3.4B	$-5.1B	$-6.5B	$-8.9B	$770.0M
CashFlow - CashReconciliationAndSupplemental - EffectOfExchangeRateChangesOnCash	$-40.0M	$57.0M	$-63.0M	$-35.0M	$43.0M
CashFlow - CashReconciliationAndSupplemental - NetChangeInCash	$3.9B	$673.0M	$74.0M	$-659.0M	$-5.6B
CashFlow - CashReconciliationAndSupplemental - IncomeTaxesPaid	$2.8B	$4.0B	$3.1B	$2.5B	$2.6B
CashFlow - CashReconciliationAndSupplemental - InterestPaid	$951.0M	$891.0M	$907.0M	$979.0M	$951.0M
CashFlow - CashReconciliationAndSupplemental - RightOfUseAssetsObtainedForLeases(nonCash)	$86.0M	$214.0M	$97.0M	$88.0M	$88.0M

Gilead Sciences

Balance Sheet 34 Accounts • 5 Years

Income Statement 20 Accounts • 5 Years

Cash Flow Statement 25 Accounts • 5 Years

Stock Market Data (1 Year) Live Yahoo Finance Data

Recent Price History